ArticleMolecular therapy. Oncology2025

Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma.

Greyson Biegert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.